Our Impact

Our scientific group is undertaking cutting-edge laboratory and clinical research making an impactful contribution to the global fight against the TB pandemic.

The research we carry out has led to the evaluation of new TB treatment and the delivery of new tools for infection control.

Over the past decade we have been in the core of many international consortia, academic research and clinical studies bringing innovation to the field of TB biomarker, diagnostics and treatment strategies.

From 2008 we have been members of the PanACEA network facilitating the collaboration with many African research laboratories, hospitals and universities advancing TB diagnosis, treatment and treatment response monitoring. This research has ultimately led to the development and commercialization of an assay for real-time detection of TB bacterial load and the patients’ response to therapy.